Evidence map›Paper›PMID 27241778›Full record

ReviewMedizinische Klinik, Intensivmedizin und Notfallmedizin2016

[Hepatorenal syndrome in decompensated cirrhosis : A special form of acute renal failure].

K Lenz, R Buder, G Lohr, P Piringer, M Voglmayr

Open access · hybridAbstract readReview
PubMed Publisher
In one paragraph

Review in Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

K LenzAbteilung für Innere Medizin und Intensivmedizin, Konventhospital der Barmherzigen Brüder Linz, Seilerstätte 2, 4020, Linz, Österreich. kurt.lenz@meduniwien.ac.at.
R BuderAbteilung für Innere Medizin und Intensivmedizin, Konventhospital der Barmherzigen Brüder Linz, Seilerstätte 2, 4020, Linz, Österreich.
G LohrAbteilung für Innere Medizin und Intensivmedizin, Konventhospital der Barmherzigen Brüder Linz, Seilerstätte 2, 4020, Linz, Österreich.
P PiringerAbteilung für Innere Medizin und Intensivmedizin, Konventhospital der Barmherzigen Brüder Linz, Seilerstätte 2, 4020, Linz, Österreich.
M VoglmayrAbteilung für Innere Medizin und Intensivmedizin, Konventhospital der Barmherzigen Brüder Linz, Seilerstätte 2, 4020, Linz, Österreich.
Convent Hospital of the Brothers of Saint John of God · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal failure is a serious complication in patients with advanced cirrhosis. It occurs in about 20 % of patients hospitalized with cirrhosis. In about 70 % it is caused by prerenal failure, and in 30 % it is due to intrarenal causes. In about 70 % of patients with rperenal failure, renal function can be restored with fluid replacement, but the remaining 30 % are unresponsive to volume expansion. Minor increase in serum creatinine have been shown to be clinically relevant and can adversely affect survival. Therefore early efforts should be made to avoid precipitation of renal failure.Hepatorenal syndrome (HRS) is a  fully reversible impairment of renal function in patients with cirrhosis unresponsive to volume expansion characterized by an acute progressive decrease in kidney function (serumcreatinin > 1,5 mg/dl) - type 1 HRS, whereas type 2 HRS features a decrease in kidney function over a long time, mostly in patients with refractory ascites. Therapy with vasoconstrictors like terlipressin to reverse splanchnic vasodilation, together with albumin is effective in 30-50 % of patients with HRS 1 and improves survival. The only effective longterm therapy is livertransplantation. An improvement of kidney fuction before transplantation is associated with a better outcome and posttransplant kidney function.

Indexed as

Critical CareFluid TherapyHepatorenal SyndromeHumansKidney Function TestsLiver CirrhosisLiver FailureLiver TransplantationLypressinPrognosisSerum AlbuminTerlipressinVasoconstrictor AgentsLypressinSerum AlbuminTerlipressinVasoconstrictor AgentsAscitesHepatitisKidney diseasesLiver diseasesPeritonitis

Identifiers

PMID27241778
OpenAlexW2408939367

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.